Back to Search
Start Over
Study of the potential adverse effects caused by the dermal application of Dillenia indica L. fruit extract standardized to betulinic acid in rodents.
- Source :
-
PloS one [PLoS One] 2019 May 31; Vol. 14 (5), pp. e0217718. Date of Electronic Publication: 2019 May 31 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- This study aimed to evaluate the potential adverse effects of the dermal administration of Dillenia indica Linnaeus (D. indica) fruit extract in healthy rodents; the extract was standardized to betulinic acid. In the initial phase, the acute effects were evaluated on the skin application site of a single extract dose. A skin irritation test was performed in male Wistar rats (n = 8/group) receiving the extract (50-150 mg/mL) with betulinic acid (0.5-1.5%, respectively). A photosensitivity test was performed in male BALB/c mice (n = 6/group) receiving the extract (150 mg/mL). Afterwards, other BALB/c mice (n = 20, male:female, 1:1) were used to assess the systemic alterations caused by 14 daily repeated doses (150 mg/mL) by monitoring the effects on mortality, body morphology, behavior, nutrition status, neuromotor reactions, organ morphology and weight, and blood tests. At this time, 0.5 mg/mL clobetasol was used as the positive control. The skin irritation index suggested that negligible skin irritation had occurred, even when the extract was applied to the rat skin at 150 mg/mL. However, the extract acted as a photosensitizer on mouse skin, showing a photosensitizing activity close to that of 10 mg/mL 5-methoxypsoralen. Repeated doses caused no mouse mortality, aggressiveness, piloerection, diarrhea, convulsions, neuromotor alterations or nutrition status changes. The mouse organ weights did not change, and the mice did not have alterations in their blood compositions. Clobetasol caused a reduction in the mononuclear leukocyte numbers. In general, the data suggest that the extract was safe in healthy rodents but indicate that caution should be taken with the photosensitizing activity; in addition, this activity should be further explored as it may be useful for phototherapeutic drug development.<br />Competing Interests: The authors have declared that no competing interests exist.
- Subjects :
- Administration, Cutaneous
Animals
Fruit chemistry
Humans
Leukocytes, Mononuclear drug effects
Mice
Pentacyclic Triterpenes
Photosensitizing Agents chemistry
Plant Extracts chemistry
Plant Extracts pharmacology
Rats
Skin Irritancy Tests
Triterpenes chemistry
Triterpenes pharmacology
Betulinic Acid
Clobetasol pharmacology
Dilleniaceae chemistry
Photosensitizing Agents pharmacology
Skin drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 14
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 31150479
- Full Text :
- https://doi.org/10.1371/journal.pone.0217718